Zurcher Kantonalbank (Zurich Cantonalbank) Aurinia Pharmaceuticals Inc. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$32.8 Billion
Q3 2024

A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 28,634 shares of AUPH stock, worth $231,076. This represents 0.0% of its overall portfolio holdings.

Number of Shares

28,634

Previous 28,634 -0.0%

Holding current value

$231,076

Previous $209,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 30, 2024	BUY	$7.13 - $9.49 $17,040 - $22,681	2,390 Added 9.11%	28,634 $257,000
Q3 2023 Oct 25, 2023	BUY	$7.77 - $12.27 $50,606 - $79,914	6,513 Added 33.01%	26,244 $203,000
Q2 2023 Aug 07, 2023	BUY	$8.96 - $11.69 $40,893 - $53,353	4,564 Added 30.09%	19,731 $190,000
Q1 2023 May 08, 2023	SELL	$5.94 - $11.27 $7,436 - $14,110	-1,252 Reduced 7.63%	15,167 $166,000
Q2 2022 Aug 09, 2022	SELL	$8.95 - $12.8 $1,100 - $1,574	-123 Reduced 0.74%	16,419 $165,000
Q1 2022 Apr 21, 2022	BUY	$10.05 - $22.48 $13,818 - $30,910	1,375 Added 9.07%	16,542 $205,000
Q4 2021 Feb 01, 2022	BUY	$17.78 - $33.08 $49,855 - $92,756	2,804 Added 22.68%	15,167 $347,000
Q3 2020 Nov 06, 2020	BUY	$13.19 - $16.66 $65,330 - $82,516	4,953 Added 66.84%	12,363 $182,000
Q2 2020 Jul 28, 2020	BUY	$14.12 - $18.33 $18,440 - $23,938	1,306 Added 21.4%	7,410 $121,000
Q4 2018 Jan 25, 2019	BUY	$5.08 - $6.83 $19,446 - $26,145	3,828 Added 168.19%	6,104 $41,000
Q3 2018 Nov 09, 2018	BUY	$5.27 - $6.64 $8,316 - $10,477	1,578 Added 226.07%	2,276 $15,000
Q2 2018 Aug 06, 2018	BUY	$5.06 - $6.36 $3,531 - $4,439	698 New	698 $4,000

Others Institutions Holding AUPH

# of Institutions

208

Shares Held

58.6M

Call Options Held

1.14M

Put Options Held

1.51M

View Full List

About Aurinia Pharmaceuticals Inc.

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.15B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

More about AUPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account

Zurcher Kantonalbank (Zurich Cantonalbank) Aurinia Pharmaceuticals Inc. Transaction History